ABBIATI, ROBERTO ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 775
EU - Europa 307
AS - Asia 66
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 1.155
Nazione #
US - Stati Uniti d'America 729
GR - Grecia 84
IT - Italia 76
SE - Svezia 47
CA - Canada 46
IE - Irlanda 30
VN - Vietnam 24
FI - Finlandia 17
DE - Germania 14
CN - Cina 12
GB - Regno Unito 11
TR - Turchia 11
UA - Ucraina 6
AT - Austria 5
CH - Svizzera 5
ES - Italia 5
JP - Giappone 5
IN - India 4
IR - Iran 4
AU - Australia 2
BR - Brasile 2
DK - Danimarca 2
FR - Francia 2
ID - Indonesia 2
IS - Islanda 2
KR - Corea 2
UG - Uganda 2
NG - Nigeria 1
NL - Olanda 1
SG - Singapore 1
TH - Thailandia 1
Totale 1.155
Città #
Fairfield 97
Woodbridge 80
Ashburn 68
Chandler 64
Seattle 62
Wilmington 61
Houston 42
Cambridge 39
Dublin 30
North York 28
Ann Arbor 26
Ottawa 18
Dearborn 17
Medford 15
Beijing 9
Izmir 9
Lawrence 8
Redwood City 8
San Diego 8
Dong Ket 7
New York 7
Helsinki 6
Milan 5
Málaga 5
Trieste 5
Vienna 5
Saarbrücken 4
Bern 3
Boardman 3
Des Moines 3
Parma 3
Redmond 3
Ankara 2
Avellino 2
Falkenstein 2
Kampala 2
Mirano 2
Monmouth Junction 2
Mountain View 2
Neviano degli Arduini 2
Norwalk 2
Pordenone 2
Reykjavík 2
Riverview 2
Salice Terme 2
Sydney 2
Acton 1
Americana 1
Bangkok 1
Bari 1
Bengaluru 1
Bologna 1
Brentford 1
Bronx 1
Busto Arsizio 1
Chicago 1
Cinisello Balsamo 1
Conselice 1
Copenhagen 1
Dunstable 1
Esslingen am Neckar 1
Frederiksberg 1
Fuzhou 1
Gunzenhausen 1
Hefei 1
Hounslow 1
Islington 1
Jacksonville 1
Kagoya 1
Maragheh 1
Phoenix 1
Rome 1
Sassari 1
Sciacca 1
Shanghai 1
Simi Valley 1
Singapore 1
Stockholm 1
São Paulo 1
Tokyo 1
Washington 1
Totale 811
Nome #
Engineering approaches in siRNA delivery 118
A new approach for pharmacokinetic model application towards personalized medicine 109
A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil 93
Definition and validation of a patient-individualized physiologically-based pharmacokinetic model 88
Enterohepatic Circulation Effect in Physiologically Based Pharmacokinetic Models: The Sorafenib Case 88
Innovations and improvements in pharmacokinetic models based on physiology 82
A modeling tool for the personalization of pharmacokinetic predictions 81
An engineering oriented approach to physiologically based pharmacokinetic and pharmacodynamic modeling 81
A PSE approach to patient-individualized physiologically-based pharmacokinetic modeling 71
PHARMACOKINETICS OF REMIFENTANIL: METABOLISM AND MODELING 69
Chemical engineering in the “BIO” world 69
A physiologically based model for tramadol pharmacokinetics in horses 65
Performance of classical and physiologically-based PK-PD modelling for prediction of remifentanil hemodynamic effects 64
Sorafenib in mice - A Pharmacokinetic study 54
MASS BALANCE: AN OLD CONCEPT FOR THE NEW CHALLENGES PROPOSED BY PERSONALIZED MEDICINE 44
Totale 1.176
Categoria #
all - tutte 3.873
article - articoli 2.151
book - libri 0
conference - conferenze 295
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.427
Totale 7.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201972 0 0 0 0 0 0 0 0 0 0 43 29
2019/2020370 17 16 5 22 26 139 33 24 31 16 26 15
2020/2021140 10 6 7 4 5 11 3 9 17 14 14 40
2021/2022138 3 6 4 19 32 8 7 11 3 8 13 24
2022/2023163 29 2 4 2 24 25 1 9 29 12 19 7
2023/2024104 4 25 3 15 6 37 1 3 2 5 3 0
Totale 1.176